{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:05:51Z","timestamp":1773288351684,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2002,2]]},"DOI":"10.1124\/jpet.300.2.549","type":"journal-article","created":{"date-parts":[[2003,7,27]],"date-time":"2003-07-27T00:50:36Z","timestamp":1059267036000},"page":"549-558","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Effect of 17-\u03b1-Ethynylestradiol on Activities of Cytochrome P450 2B (P450 2B) Enzymes: Characterization of Inactivation of P450s 2B1 and 2B6 and Identification of Metabolites"],"prefix":"10.1016","volume":"300","author":[{"given":"Ute M.","family":"Kent","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle E.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajendram V.","family":"Rajnarayanan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William L.","family":"Alworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul F.","family":"Hollenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.300.2.549_bib1","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/0006-2952(93)90326-R","article-title":"A highly sensitive tool for the assay of cytochrome P450 enzyme activity in rat, dog and man.","volume":"46","author":"Buters","year":"1993","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.300.2.549_bib2","first-page":"985","article-title":"Human cytochrome P450 2B6: interindividual hepatic expression, substrate specificity, and role in procarcinogen activation.","volume":"25","author":"Code","year":"1997","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.300.2.549_bib3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0076-6879(78)52012-0","article-title":"Two forms of liver microsomal cytochrome P450, P450 LM2 and P450 LM4 (rabbit liver).","volume":"52","author":"Coon","year":"1978","journal-title":"Methods Enzymol"},{"key":"10.1124\/jpet.300.2.549_bib4","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nsb0295-144","article-title":"Structure of cytochrome P450eryF involved in erythromycin biosynthesis.","volume":"2","author":"Cupp-Vickery","year":"1995","journal-title":"Nat Struct Biol"},{"key":"10.1124\/jpet.300.2.549_bib5","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0026-895X(24)12054-8","article-title":"Validation of buprion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity.","volume":"28","author":"Faucette","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.300.2.549_bib6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0021-9258(18)48462-1","article-title":"Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analysis of amino acid and coding nucleotide sequences.","volume":"267","author":"Gotoh","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.300.2.549_bib7","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0026-895X(25)13356-7","article-title":"Oxidation of 17\u03b1-ethymylestradiole by human liver cytochrome P450.","volume":"33","author":"Guengerich","year":"1988","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.300.2.549_bib8","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/0024-3205(90)90431-P","article-title":"Metabolism of 17\u03b1-ethynylestradiol in humans.","volume":"47","author":"Guengerich","year":"1990","journal-title":"Life Sci"},{"key":"10.1124\/jpet.300.2.549_bib9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.pa.35.040195.000333","article-title":"Structural basis of selective cytochrome P450 inhibition.","volume":"35","author":"Halpert","year":"1995","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/jpet.300.2.549_bib10","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1006\/abbi.2000.1708","article-title":"Expression of human cytochrome P450 2B6 in Escherichia coli: characterization of catalytic activity and expression in human liver.","volume":"376","author":"Hanna","year":"2000","journal-title":"Arch Biochem"},{"key":"10.1124\/jpet.300.2.549_bib11","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1021\/bi971528s","article-title":"Molecular basis for the difference in lidocaine binding and the regioselectivity of oxidation by cytochrome P450 2B1 and 2B2.","volume":"37","author":"Hanna","year":"1998","journal-title":"Biochemistry"},{"key":"10.1124\/jpet.300.2.549_bib12","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1006\/abbi.1997.0534","article-title":"Role of alanine at position 363 of cytochrome P450 2B2 in influencing the NADPH- and hydroperoxide-supported activities.","volume":"350","author":"Hanna","year":"1998","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/jpet.300.2.549_bib13","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1021\/tx950177k","article-title":"Identification of the heme adduct and an active site peptide modified during mechanism-based inactivation of rat liver cytochrome P450 2B1 by secobarbital.","volume":"9","author":"He","year":"1996","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/jpet.300.2.549_bib14","first-page":"886","article-title":"Characterization of cytochrome P450 enzymes in human breast tissue from reduction mammoplasties.","volume":"83","author":"Hellmold","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1124\/jpet.300.2.549_bib15","first-page":"100","article-title":"Ritonavir, Efavirenz, and Nelfinavir inhibit CYP2B6 activity in vitro: potential drug interactions with bupropion.","volume":"29","author":"Hesse","year":"2001","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.300.2.549_bib16","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/BF01681040","article-title":"Neue per os-wirksame weibliche Keimdr\u00fcsenhormon-Derivate: 17-\u00c4thinyl\u00f6stradiol und Pregnene-in-on-3-ol-17.","volume":"26","author":"Innhoffen","year":"1938","journal-title":"Naturwissenschaften"},{"key":"10.1124\/jpet.300.2.549_bib17","doi-asserted-by":"crossref","first-page":"22515","DOI":"10.1016\/S0021-9258(18)54602-0","article-title":"Molecular basis for a functionally unique cytochrome P450IIBI.","volume":"266","author":"Kedzie","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.300.2.549_bib18","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2174\/1389200013338478","article-title":"Mechanism-based inactivators as probes of cytochrome P450 structure and function.","volume":"2","author":"Kent","year":"2001","journal-title":"Curr Drug Metabol"},{"key":"10.1124\/jpet.300.2.549_bib19","unstructured":"Madan A, LeCluyse EL, Foster J, Carroll K, Lantham JD, Yang D, and Parkinson A (1996) Identification and characterization of cytochrome P450 2B6 (CYP2B6) in human liver microsomes and its induction in primary cultures of human hepatocytes. XI International Symposium on Microsomes and Drug Oxidations; 1996 July 21\u201324; Los Angeles, CA. pp 203."},{"key":"10.1124\/jpet.300.2.549_bib20","first-page":"877","article-title":"Cotinine formation by cDNA expressed human cytochromes P450.","volume":"20","author":"McCracken","year":"1992","journal-title":"Med Sci Res"},{"key":"10.1124\/jpet.300.2.549_bib21","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0090-9556(25)08198-X","article-title":"Characterization of cytochrome P-450 2B6 in human liver microsomes.","volume":"21","author":"Mimura","year":"1993","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.300.2.549_bib22","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1016\/S0021-9258(20)82244-3","article-title":"The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemo protein nature.","volume":"239","author":"Omura","year":"1964","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.300.2.549_bib23","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3109\/00498259609046742","article-title":"Specificity of substrate and inhibitor probes for cytochrome P450s: evaluation of in vitro metabolism using cDNA expressed human P450s and human liver microsomes.","volume":"26","author":"Ono","year":"1996","journal-title":"Xenobiotica"},{"key":"10.1124\/jpet.300.2.549_bib24","series-title":"Cytochrome P-450: Structure, Mechanism and Biochemistry","first-page":"273","article-title":"Inhibition of cytochrome P450 enzymas","author":"Ortiz de Montellano","year":"1986"},{"key":"10.1124\/jpet.300.2.549_bib25","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1093\/jnci\/85.23.1917","article-title":"Upregulation of estradiol C16 alpha-hydroxylation in human breast tissue: a potential biomarker of breast cancer risk.","volume":"85","author":"Osborne","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1124\/jpet.300.2.549_bib26","doi-asserted-by":"crossref","first-page":"13469","DOI":"10.1016\/S0021-9258(18)92717-1","article-title":"Cytochrome P450. Multiplicity of isoforms, substrates, and catalytic and regulatory mechanisms.","volume":"266","author":"Porter","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.300.2.549_bib27","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1126\/science.8342039","article-title":"Crystal structure of hemoprotein domain of P450 BM-3, a prototype for microsomal P450s.","volume":"261","author":"Ravichandran","year":"1993","journal-title":"Science (Wash DC)"},{"key":"10.1124\/jpet.300.2.549_bib28","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3109\/03602539709037591","article-title":"Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors.","volume":"29","author":"Rendic","year":"1997","journal-title":"Drug Metabol Rev"},{"key":"10.1124\/jpet.300.2.549_bib29","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/S0021-9258(19)70076-3","article-title":"Purification to homogeneity and characterization of a form of cytochrome P450 with high specificity for benzopyrene from beta-naphtoflavone-pretreated rat liver microsomes.","volume":"256","author":"Saito","year":"1981","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.300.2.549_bib30","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0090-9556(25)08063-8","article-title":"Cytochrome P-450-dependent oxidation of the 17\u03b1-ethynyl group of synthetic steroids.","volume":"11","author":"Schmid","year":"1983","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.300.2.549_bib31","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0022-3565(25)22379-5","article-title":"Interindividual variation in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.","volume":"270","author":"Shimada","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.300.2.549_bib32","series-title":"Contemporary Enzyme Kinetics and Mechanisms","first-page":"291","article-title":"Mechanism-based enzyme inactivators","author":"Silverman","year":"1996"},{"key":"10.1124\/jpet.300.2.549_bib33","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0022-3565(24)36941-1","article-title":"Human liver CYP-2B6-catalyzed hydroxylation of RP 73401.","volume":"282","author":"Stevens","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.300.2.549_bib34","doi-asserted-by":"crossref","first-page":"11697","DOI":"10.1021\/bi9710176","article-title":"Reassessment of cytochrome P450 2B2: catalytic specificity and identification of four active site residues.","volume":"36","author":"Strobel","year":"1997","journal-title":"Biochemistry"},{"key":"10.1124\/jpet.300.2.549_bib35","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/carcin\/15.1.5","article-title":"Genotoxicity of tamoxifen, tamoxifen epoxide and tormifene in human lymphoblastoid cells containing human cytochrome P450s.","volume":"15","author":"Styles","year":"1994","journal-title":"Carcinogenesis"},{"key":"10.1124\/jpet.300.2.549_bib36","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0022-3565(25)24305-1","article-title":"High performance liquid chromatography separation of hydroxylated estradiol metabolites: formation of estradiol metabolites by liver microsomes from male and female rats.","volume":"272","author":"Suchar","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.300.2.549_bib37","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1097-2765(00)80408-6","article-title":"Mammalian microsomal cytochrome P450 monooxygenase structural adaptations for membrane binding and functional diversity.","volume":"5","author":"Williams","year":"2000","journal-title":"Mol Cell"},{"key":"10.1124\/jpet.300.2.549_bib38","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0039-128X(75)90135-X","article-title":"The urinary metabolites of 17\u03b1-ethynylestradiol-9\u03b1,11\u03be-3H in women. Chromatographic profiling and identification of ethynyl and non-ethynyl compounds.","volume":"25","author":"Williams","year":"1975","journal-title":"Steroids"},{"key":"10.1124\/jpet.300.2.549_bib39","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0006-2952(95)02178-7","article-title":"7-ethoxycoumarin O-deethylation catalyzed by cytochromes P4501A2 and 2E1 in human liver microsomes.","volume":"51","author":"Yamazaki","year":"1996","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.300.2.549_bib40","first-page":"887","article-title":"Involvement of CYP2B6 in N-demethylation of ketamine in human liver microsomes.","volume":"29","author":"Yanagihara","year":"2001","journal-title":"Drug Metab Dispos"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524354850?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524354850?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.300.2.549","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T23:13:49Z","timestamp":1740006829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524354850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,2]]}},"alternative-id":["S0022356524354850"],"URL":"https:\/\/doi.org\/10.1124\/jpet.300.2.549","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2002,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of 17-\u03b1-Ethynylestradiol on Activities of Cytochrome P450 2B (P450 2B) Enzymes: Characterization of Inactivation of P450s 2B1 and 2B6 and Identification of Metabolites","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.300.2.549","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2002 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}